Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.
Cannon CP, Gibson CM, McCabe CH, Adgey AA, Schweiger MJ, Sequeira RF, Grollier G, Giugliano RP, Frey M, Mueller HS, Steingart RM, Weaver WD, Van de Werf F, Braunwald E. Cannon CP, et al. Among authors: grollier g. Circulation. 1998 Dec 22-29;98(25):2805-14. doi: 10.1161/01.cir.98.25.2805. Circulation. 1998. PMID: 9860780 Clinical Trial.
Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators.
Gibson CM, Cannon CP, Murphy SA, Adgey AA, Schweiger MJ, Sequeira RF, Grollier G, Fox NL, Berioli S, Weaver WD, Van de Werf F, Braunwald E. Gibson CM, et al. Among authors: grollier g. Am J Cardiol. 1999 Nov 1;84(9):976-80. doi: 10.1016/s0002-9149(99)00483-x. Am J Cardiol. 1999. PMID: 10569649 Clinical Trial.
A synthetic factor-Xa inhibitor (ORG31540/SR9017A) as an adjunct to fibrinolysis in acute myocardial infarction. The PENTALYSE study.
Coussement PK, Bassand JP, Convens C, Vrolix M, Boland J, Grollier G, Michels R, Vahanian A, Vanderheyden M, Rupprecht HJ, Van de Werf F; PENTALYSE investigators. Coussement PK, et al. Among authors: grollier g. Eur Heart J. 2001 Sep;22(18):1716-24. doi: 10.1053/euhj.2001.2777. Eur Heart J. 2001. PMID: 11511121 Clinical Trial.
Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day clinical outcome of the French Multicenter Registry.
Karrillon GJ, Morice MC, Benveniste E, Bunouf P, Aubry P, Cattan S, Chevalier B, Commeau P, Cribier A, Eiferman C, Grollier G, Guerin Y, Henry M, Lefevre T, Livarek B, Louvard Y, Marco J, Makowski S, Monassier JP, Pernes JM, Rioux P, Spaulding C, Zemour G. Karrillon GJ, et al. Among authors: grollier g. Circulation. 1996 Oct 1;94(7):1519-27. doi: 10.1161/01.cir.94.7.1519. Circulation. 1996. PMID: 8840839 Clinical Trial.
Effect of nadroparin, a low-molecular-weight heparin, on clinical and angiographic restenosis after coronary balloon angioplasty: the FACT study. Fraxiparine Angioplastie Coronaire Transluminale.
Lablanche JM, McFadden EP, Meneveau N, Lusson JR, Bertrand B, Metzger JP, Legrand V, Grollier G, Macaya C, de Bruyne B, Vahanian A, Grentzinger A, Masquet C, Wolf JE, Tobelem G, Fontecave S, Vacheron A, d'Azemar P, Bertrand ME. Lablanche JM, et al. Among authors: grollier g. Circulation. 1997 Nov 18;96(10):3396-402. doi: 10.1161/01.cir.96.10.3396. Circulation. 1997. PMID: 9396433 Clinical Trial.
Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial.
Neuhaus KL, Molhoek GP, Zeymer U, Tebbe U, Wegscheider K, Schröder R, Camez A, Laarman GJ, Grollier GM, Lok DJ, Kuckuck H, Lazarus P. Neuhaus KL, et al. Among authors: grollier gm. J Am Coll Cardiol. 1999 Oct;34(4):966-73. doi: 10.1016/s0735-1097(99)00319-8. J Am Coll Cardiol. 1999. PMID: 10520777 Free article. Clinical Trial.
303 results